NIH Awards UB $28.4 Million for Translational Science
The University at Buffalo (UB) has received $28.4 million from the National Institutes of Health (NIH) to advance its Clinical and Translational Science Award (CTSA) program. This funding, the university's third CTSA since 2015, brings UB's total NIH support for translational research to more than $65 million. The program's goal is to bridge the gap between research findings and improved community health outcomes, with a strong emphasis on reducing disparities.
Focus on Health Equity and Community Needs The CTSA at UB is a collaboration among UB’s five health sciences schools, Roswell Park Comprehensive Cancer Center, and numerous community partners. The initiative emphasizes solving regional health challenges, particularly those affecting vulnerable populations, by translating cutting-edge research into actionable solutions.
“The renewed funding underscores UB’s leadership in tackling health disparities and driving transformative healthcare innovation,” said UB President Satish K. Tripathi.
Significant Milestones and Achievements UB’s CTSA has delivered impactful results:
Community Impact Initiatives: Addressed pandemic-related health disparities and provided mental health support following the May 14, 2022, mass shooting in Buffalo. Clinical Trial Diversity: Achieved 24% participation from underrepresented groups in clinical trials, far exceeding the national average of less than 10%. Asthma Interventions for Children: School-based asthma care programs in Buffalo Public Schools have reduced emergency room visits and absenteeism while improving academic outcomes.
With the new funding, UB will implement several initiatives aimed at deepening its community impact:
Training Community Health Workers: Workers will conduct health screenings and provide wellness resources in underserved neighborhoods to reduce barriers to care. Expanding Pilot Research Projects: Previous projects funded through the CTSA have demonstrated an 11:1 return on investment by securing additional external research funding. Enhanced Community Engagement: Strengthening partnerships with local organizations to ensure that research addresses pressing community health needs. Long-Term Vision Through the CTSA, UB is positioned to lead significant advancements in healthcare by ensuring that scientific discoveries directly benefit patients. The program will continue to focus on health equity, community collaboration, and addressing the unique challenges faced by Western New York’s diverse population.
“This funding empowers UB to tackle the toughest health challenges, improve lives, and make a tangible difference in our community,” Tripathi added.